Blood lead testing definition
Blood lead testing means taking a capillary or venous sample of blood and sending it to a laboratory to determine the level of lead in the blood.
Blood lead testing means taking a capillary or venous sample of blood for point of care testing using a Clinical Laboratory Improvement Act of 1988 (CLIA) licensed or waived test or sending it to a laboratory to determine the level of lead in the blood.
Blood lead testing means taking a capillary or venous
Examples of Blood lead testing in a sentence
Examples of areas of clinical priority and measurement studies include: • Immunization rates • Early and Periodic Screening, Diagnosis and Treatment (EPSDT) service utilization • Prenatal care • Blood lead testing • Emergency room utilization • Access to care • Special needs care coordination and utilization • Report any national performance measures developed by CMS.
More Definitions of Blood lead testing
Blood lead testing. All screening must be done through a blood lead level determination. The contractor must implement a screening program to identify and treat high-risk children for leadexposure and toxicity. The screening program shall include blood level screening, diagnostic evaluation and treatment with follow-up care of children whose blood lead levels are elevated. The EP test is no longer acceptable as a screening test for lead poisoning; however, it is still valid as a screening test for iron deficiency anemia. Screening blood lead testing may be performed by either a capillary sample (fingerstick) or a venous sample. However, all elevated blood levels (equal to or greater than ten (10) micrograms per one (1) deciliter) obtained through a capillary sample must be confirmed by a venous sample. The blood lead test must be performed by a New Jersey Department of Health and Senior Services licensed laboratory. The frequency with which the blood test is to be administered depends upon the results of the verbal risk assessment. For children determined to be at low risk for high doses of lead exposure, a screening blood lead test must be performed once between the ages of nine (9) and eighteen (18) months, preferably at twelve (12) months, once between 18-26 months, preferably at twenty-four (24) months, and for any child between twenty-seven (27) and seventy-two (72) months not previously tested. For children determined to be at high risk for high doses of lead exposure, a screening blood test must be performed at the time a child is determined to be a high risk beginning at six months of age if there is pertinent information or evidence that the child may be at risk at younger ages than stated in 4.2.6B.1.
i. If the initial blood lead test results are less than ten (10) micrograms per deciliter, a verbal risk assessment is required at every subsequent periodic visit through seventytwo (72) months of age, with mandatory blood lead testing performed according to the schedule in 4.2.6B.
ii. If the child is found to have a blood lead level equal to or greater than ten (10) micrograms per deciliter, providers should use their professional judgment, in accordance with the CDC guidelines regarding patient management and treatment, as well as follow-up blood test.
iii. If a child between the ages of twenty-four (24) months and seventy-two (72) months has not received a screening blood lead test, the child must receive the blood lead test immediately, regardless of whether the ch...